| NY-ESO-1–specific TCR–engineered T cells mediate sustained antigen-specific antitumor effects in myeloma AP Rapoport, EA Stadtmauer, GK Binder-Scholl, O Goloubeva, DT Vogl, ... Nature medicine 21 (8), 914-921, 2015 | 1021 | 2015 |
| Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors A Badros, D Weikel, A Salama, O Goloubeva, A Schneider, A Rapoport, ... Journal of clinical oncology 24 (6), 945-952, 2006 | 806 | 2006 |
| Proteasome inhibitor PS-341 inhibits human myeloma cell growth in vivo and prolongs survival in a murine model R LeBlanc, LP Catley, T Hideshima, S Lentzsch, CS Mitsiades, ... Cancer research 62 (17), 4996-5000, 2002 | 636 | 2002 |
| Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial MR Posner, JH Lorch, O Goloubeva, M Tan, LM Schumaker, NJ Sarlis, ... Annals of oncology 22 (5), 1071-1077, 2011 | 552 | 2011 |
| Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results … JH Lorch, O Goloubeva, RI Haddad, K Cullen, N Sarlis, R Tishler, M Tan, ... The lancet oncology 12 (2), 153-159, 2011 | 517 | 2011 |
| Patterns of intellectual development among survivors of pediatric medulloblastoma: a longitudinal analysis SL Palmer, O Goloubeva, WE Reddick, JO Glass, A Gajjar, L Kun, ... Journal of clinical oncology 19 (8), 2302-2308, 2001 | 495 | 2001 |
| Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses EA Govorkova, IA Leneva, OG Goloubeva, K Bush, RG Webster Antimicrobial Agents and Chemotherapy 45 (10), 2723-2732, 2001 | 361 | 2001 |
| Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients K Settle, MR Posner, LM Schumaker, M Tan, M Suntharalingam, ... Cancer prevention research 2 (9), 776-781, 2009 | 346 | 2009 |
| Phase I study of vorinostat in combination with bortezomib for relapsed and refractory multiple myeloma A Badros, AM Burger, S Philip, R Niesvizky, SS Kolla, O Goloubeva, ... Clinical Cancer Research 15 (16), 5250-5257, 2009 | 288 | 2009 |
| Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer TC Walser, S Rifat, X Ma, N Kundu, C Ward, O Goloubeva, MG Johnson, ... Cancer research 66 (15), 7701-7707, 2006 | 280 | 2006 |
| The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses IA Leneva, N Roberts, EA Govorkova, OG Goloubeva, RG Webster Antiviral research 48 (2), 101-115, 2000 | 274 | 2000 |
| Neurotoxicity of bortezomib therapy in multiple myeloma: a single‐center experience and review of the literature A Badros, O Goloubeva, JS Dalal, I Can, J Thompson, AP Rapoport, ... Cancer 110 (5), 1042-1049, 2007 | 264 | 2007 |
| Pembrolizumab, pomalidomide, and low-dose dexamethasone for relapsed/refractory multiple myeloma A Badros, E Hyjek, N Ma, A Lesokhin, A Dogan, AP Rapoport, M Kocoglu, ... Blood, The Journal of the American Society of Hematology 130 (10), 1189-1197, 2017 | 206 | 2017 |
| Metformin prevents liver tumorigenesis by inhibiting pathways driving hepatic lipogenesis K Bhalla, BJ Hwang, RE Dewi, W Twaddel, OG Goloubeva, KK Wong, ... Cancer prevention research 5 (4), 544-552, 2012 | 199 | 2012 |
| α-Tubulin acetylation elevated in metastatic and basal-like breast cancer cells promotes microtentacle formation, adhesion, and invasive migration AE Boggs, MI Vitolo, RA Whipple, MS Charpentier, OG Goloubeva, ... Cancer research 75 (1), 203-215, 2015 | 193 | 2015 |
| CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine model X Ma, K Norsworthy, N Kundu, WH Rodgers, PA Gimotty, O Goloubeva, ... Molecular cancer therapeutics 8 (3), 490-498, 2009 | 187 | 2009 |
| Functional activation of the estrogen receptor-α and aromatase by the HDAC inhibitor entinostat sensitizes ER-negative tumors to letrozole GJ Sabnis, O Goloubeva, S Chumsri, N Nguyen, S Sukumar, AMH Brodie Cancer research 71 (5), 1893-1903, 2011 | 186 | 2011 |
| Natural history of osteonecrosis of the jaw in patients with multiple myeloma A Badros, E Terpos, E Katodritou, O Goloubeva, E Kastritis, E Verrou, ... Journal of clinical oncology 26 (36), 5904-5909, 2008 | 175 | 2008 |
| Ultrasound use during cardiopulmonary resuscitation is associated with delays in chest compressions MAH In't Veld, MG Allison, DS Bostick, KR Fisher, OG Goloubeva, ... Resuscitation 119, 95-98, 2017 | 173 | 2017 |
| Activation of mitogen-activated protein kinase in xenografts and cells during prolonged treatment with aromatase inhibitor letrozole D Jelovac, G Sabnis, BJ Long, L Macedo, OG Goloubeva, AMH Brodie Cancer research 65 (12), 5380-5389, 2005 | 158 | 2005 |
